logo
Honey-Sweetened ‘Ice Cream For Bears' Is The Poster Child For Clean Ingredients

Honey-Sweetened ‘Ice Cream For Bears' Is The Poster Child For Clean Ingredients

Forbes5 days ago
Tim Berg is a simple guy.
He likes eating fresh foods and spending time outdoors.
Ice Cream for Bears is Berg's experiment to prove that nature's bare gifts are beyond plentiful to satisfy our cravings.
After two years in the wilderness, Ice Cream for Bears is entering thousands of stores, including Kroger banner stores, and rolling out a panoply of grizzly flavors.
'It makes me sad when people think they can't have things that are delicious because they're trying to be healthy,' Berg tells me. 'Everything behind the Ice Cream for Bears brand is to try and eat things in the form closest to which they were eaten ten thousand years ago.'
Raw, Unfiltered Honey And Pasture-Raised Dairy
As any wild bear would, Ice Cream for Bears strictly sources raw and unfiltered honey as its sole sweetener. The honey never gets heated to extreme temperatures in order to maintain its natural properties. 'You have this substitute in nature that is just as potent, if not more, than those other sweeteners,' Berg says. 'It's a rare moment where nature has the answer in spades to what's been processed.'
Just like watermelon's peak in the summer and squash's in autumn, honey is also seasonal and takes on the characteristics of its geography. So as opposed to overly-standardized honey, customers may notice slight changes in taste when eating Ice Cream for Bears depending on the time of year.
The mild honey blend is sourced from parts of Europe and South America. The processing, as opposed to any ultra-processing, simply filters out beeswax and other contaminants. 'All of our honey is tested to confirm origin, tested for foreign sugar contamination, tested to confirm enzyme activity is high and has not been degraded by heat,' Berg says.
Honey is rare to find as a sweetener in ice cream, largely because it's a more expensive sweetener and its water content can make it difficult to work with. But once perfected, it can be the secret strategy for a velvety consistency. 'Honey is an antifreeze,' Berg explains. '[Our ice cream]
has a softness to it…that is all honey.'
In terms of its dairy, Berg wouldn't compromise on sourcing grass-fed. 'Thats what cows are supposed to be eating,' he says. He found reliable partners in Working Cows Dairy in Slocomb, Alabama. The organic farm, which is also Certified Grassfed by A Greener World, provides a custom dairy blend with a high milkfat percentage to Ice Cream for Bears.
'We're not making this for anybody else,' says Jonny de Jong, whose family owns and operates Working Cows Dairy, which also performs all of the dairy processing on the estate. '[Ice Cream for Bears is] trying to be different and simple and that is a challenge, but also creates a remarkable product.'
Working Cows Dairy is working towards gaining a certification for its regenerative agriculture practices. As a farm with high animal welfare and grazing standards, these cattle have constant access to pasture. Rotational grazing on the farm allows the grass' roots to keep growing once it's eaten to help maintain a strong root structure, and in return, healthy soil. '[Berg] understands that we're going to face challenges working with nature,' de Jong says. 'They're supporting us as a local farm, so that means a lot to us down here.'
Other than dairy and honey, the only ingredient in the base of Ice Cream for Bears is egg, which makes it a French ice cream. Other ingredients for individual flavors include extracts like vanilla or orange for the Roar-ange Cream flavor, cacao nibs for Chocturnal, coffee for Bearista and vanilla bean for Queen & Bean.
This fall, Ice Cream for Bears will add three new flavors to its lineup: Dough Bear (cookie dough made from dates), Churro and Burrow (cinnamon) and Cubbies & Cream (cookies & cream).
'As we grow,' Berg says, 'I want our sourcing, our supply chain to get even better.'
Scoop School
Berg has always had an affinity for the outdoors and connecting with nature, which has inspired his personal diet of minimal processed foods. But still, he would battle his sweet tooth. 'I was looking for something sweet and delicious that would fill this sort-of ancestral criteria that I formed for myself in my way of eating,' he says.
Ice Cream for Bears began with a flimsy ice cream maker while Berg earned a Master's in entrepreneurship at Washington University in St. Louis, before a pitch competition changed its trajectory. 'This guy–Steve Christensen, one of my favorite people in the world–was invited to be a judge,' Berg says. 'He owns this place in St. Louis called Scoop School.' Berg finally got his hands on some commercial equipment when Christensen invited him to Scoop School, which teaches the tricks and trades of opening an ice cream shop.
The moment he graduated, Berg sold his first pint of Ice Cream for Bears, beginning with farmers markets in St. Louis, graduating to some local shops. A proud moment was when he was able to upgrade his ice cream maker to a Musso Lussino. Ice Cream for Bears is now made with a co-manufacturer in Wisconsin. In early 2024, about two years later, Ice Cream for Bears landed its first major account with Sprouts Farmers Market.
Ice Cream For Everyone
'It was a wild couple of months,' Berg says about raising money to ramp up production for more than 400 Sprouts stores nationwide. He was still running just on the $8,000 he invested from his own bank account. Ice Cream for Bears is now a permanent staple in Sprouts' ice cream set.
By the end of 2025, Ice Cream for Bears will be in nearly 5,000 stores nationwide. That's not just natural grocers like Sprouts and Fresh Thyme Market, but conventional ones like Raley's and Kroger. Landing on a price point of $7.99, Berg was willing to sacrifice a couple of dollars per pint so that most anyone could access a clean yet awesomely delicious ice cream. 'Velocity has really helped us survive on lower margins,' Berg says.
The provocative name helps drive those velocities, making shoppers do a double-take when browsing for ice cream. The simplicity of the name reflects the simplicity of what's inside and masterfully explains the type of sweetener used. It also leaves an opening for future line extensions, like Hot Fudge for Bears, which will debut soon.
Ice Cream for Bears' Creative and Marketing Director Tara Berg led the branding effort. 'The logo itself is very cartoony and friendly and fun,' she says. Tara, who also happens to be Berg's sister, has created an entire universe of two-dimensional bears in a range of scenarios where it would be slobbering down honey. 'It's always a marriage of this serious and cool nature imagery, but we make it a little more whimsical.'
That whimsical feeling correlates with the brand's more blunt tone about ingredients used in our food system. 'We are not afraid to call out the things we don't like in the food industry', Tara says. 'We try to be transparent and authentic and give people a peek behind the curtain because we're really proud of everything we do and how we source,' she continues. 'We want other companies to try to do the same.'
Berg simply wants his product to be an example of what our food system should look like. 'This value system that I feel so strongly about has helped me in my own life, and I can share it with people through this product that isn't asking them to sacrifice anything,' he says. 'Everything going into this product is fit for a bear, this icon of the wilderness.'
As the brand likes to say, the future of food is in the past.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Macquarie to Buy Stake in Portuguese Hospital Group Luz Saude
Macquarie to Buy Stake in Portuguese Hospital Group Luz Saude

Bloomberg

time2 hours ago

  • Bloomberg

Macquarie to Buy Stake in Portuguese Hospital Group Luz Saude

Macquarie Group Ltd. is set to buy a minority stake in Portuguese hospital operator Luz Saude SA, outbidding rivals CVC Capital Partners Plc and KKR & Co., according to people familiar with the matter. Sydney-based Macquarie agreed to purchase about 40% of Luz Saude from Fidelidade-Companhia de Seguros SA, a Portuguese insurer controlled by Chinese conglomerate Fosun International Ltd, said the people, who asked not to be named because the information is confidential. The deal could be signed in the coming days and would give Luz Saude an enterprise value of more than €1 billion, one of the people said.

Denmark Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, H. Lundbeck, Leo, Orifarm, ALK-Abell, Xellia, Takeda, Sandoz, Ferring Pharmaceuticals, FUJIFILM
Denmark Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, H. Lundbeck, Leo, Orifarm, ALK-Abell, Xellia, Takeda, Sandoz, Ferring Pharmaceuticals, FUJIFILM

Yahoo

time3 hours ago

  • Yahoo

Denmark Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, H. Lundbeck, Leo, Orifarm, ALK-Abell, Xellia, Takeda, Sandoz, Ferring Pharmaceuticals, FUJIFILM

Denmark's pharmaceutical market is projected to grow from US$ 3.81 billion in 2024 to US$ 5.20 billion by 2033, with a CAGR of 3.52%. Key drivers include advanced health data infrastructure, supportive government policies, heavy R&D investment, and contributions from pharmaceutical giants like Novo Nordisk and Lundbeck. The aging population, rise in chronic diseases, and demand for innovative treatments further fuel growth. However, challenges such as regulatory complexity and sustainability pressures persist. The market encompasses a wide range of therapeutic classes and distribution channels, making Denmark a competitive hub for pharmaceutical R&D and innovation. Danish Pharmaceutical Market Dublin, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The "Denmark Pharmaceutical Market - Drug Development & Forecast 2025-2033" report has been added to Pharmaceutical Market is expected to reach US$ 5.20 billion by 2033 from US$ 3.81 billion in 2024, with a CAGR of 3.52% from 2025 to 2033 Heavy R&D spending, government assistance, well-developed healthcare system, aging population, growth in the incidence of chronic diseases, advances in biotechnology, world demand for exports, and the location of world-class pharmaceutical giants such as Novo Nordisk and Lundbeck are all determinants of Denmark's expanding pharmaceutical market. Investigation, research, production, and promotion of drugs and therapies utilized to cure, prevent, or control disease fall within the pharmaceutical sector. Through the provision of innovative medical treatments and increased life expectancy and quality of life, it plays an important role in world medicine. Scientific breakthroughs, government approvals, and the ongoing demand for effective treatments drive this industry. Both small biotech firms and international corporations are prominent players. Prescription drugs, vaccines, and over-the-counter drugs are all pharmaceuticals. The sector often collaborates with research and clinical institutions to accelerate development and is highly regulated to ensure safety and efficacy of R&D expenditures, a collaborative academic and health environment, and supportive government regulations are the primary impetus for Denmark's pharmaceutical industry. Major contributions are made by leading global companies such as Novo Nordisk and Lundbeck through specialty medicine creation and global exports. Demand within the domestic market is also boosted by an aging population and the spread of chronic diseases such as diabetes. Innovation through personalized therapy and real-world evidence creation are enabled by advanced health data infrastructure in Denmark. Its global competitiveness is enhanced by an open regulatory system and access to EU markets. These combine to offer a robust, future-proof pharmaceutical sector with scope to Drivers for the Denmark Pharmaceutical Market Advanced Health Data InfrastructureOne of the key drivers for Denmark's pharmaceutical market's growth is its advanced heath data infrastructure. With biobanks, illness registries, and population-level electronic health records, the country boasts one of the most advanced and unified systems of healthcare data in the world. Since every Danish citizen is assigned a personal identification number, medical records can be exactly correlated between clinics, hospitals, and pharmacies. The approach opens up real-world data to academics and pharma companies to facilitate post-marketing surveillance, drug development, and clinical trials. Such access reduces the cost and time-to-market of research as well as speeds up pharmacovigilance and personalized treatment innovation. It also enhances the quality and efficiency of clinical trials by enabling long-term follow-up and targeted patient recruitment. In addition, Denmark is a safe destination for international collaboration due to the stringent data protection legislation that ensures patient confidentiality. This technological advantage enhances Denmark's competitiveness in the life sciences world and makes it a leading site for pharmaceutical R& Government PoliciesDenmark's pharma industry is growing largely due to the favorable government policies of the country. Denmark has established a comprehensive Life Sciences Growth Plan incorporating 36 initiatives across six key areas such as clinical trials, R&D, and regulatory environments. This strategic plan aims to further consolidate Denmark's reputation as a leading life sciences nation by fostering innovation and streamlining establishment of a "one-stop-shop" for drug companies that simplifies and quickens the regulatory approval process is an essential component of this program. By reducing administrative barriers, this program makes it easier for businesses to set up and expand production sites in Denmark. In addition, Denmark's climate agreement with the pharmaceutical industry illustrates its commitment to environmental responsibility. Consistent with international environmental aims, our partnership works to support green innovation and reduce CO2 emissions. Overall, taken as a package, all these beneficial government programs offer a good environment for pharmaceutical companies to expand, innovate, and become globally competitive for Denmark's pharmaceutical R&D InvestmentHigh investment in research and development (R&D) is one of the factors propelling the growth of the pharmaceutical market in Denmark. With a significant proportion being allocated to life sciences and pharmaceuticals, the country has some of the highest R&D expenditures per GDP of any nation globally. Both the public funding of the Danish government and substantial contributions from the private sector - particularly from major players such as Novo Nordisk and Lundbeck - funding this hospitals, and enterprise are in close collaboration to facilitate Denmark's R&D environment that encourages innovation in biotechnology, personalized medicine, and drug development. Tax reductions, subsidies, and strategic initiatives such as the Life Sciences Growth Plan are some of the government measures that actively encourage R&D. Contemporary research infrastructure and highly skilled staff are also available, which adds to Denmark's competitive edge. This robust R&D climate accelerates the development of novel treatments, attracts foreign partnerships, and makes Denmark a world leader in clinical excellence and pharmaceutical in the Denmark Pharmaceutical Market Regulatory Complexity and EU ComplianceEU compliance and regulatory complexity provide major obstacles for Denmark's pharmaceutical industry. Businesses have to deal with two sets of regulations: strict European Union guidelines and Danish state laws. This results in a complicated and frequently drawn-out approval process for new medications and clinical studies, which can raise expenses and postpone market entry. Startups and small and medium-sized businesses (SMEs) frequently find it difficult to satisfy these standards due to the resource requirements and administrative load. Furthermore, ongoing adaptation is necessary due to the EU's periodic revisions and harmonization initiatives. For Danish pharmaceutical businesses, sustaining innovation speed while balancing compliance is still a major and Green TransitionFor Denmark's pharmaceutical industry, sustainability and the green transition pose increasing obstacles. There is growing pressure on the business to lessen its environmental impact, which includes controlling water use in manufacturing processes, cutting carbon emissions, and limiting waste. Significant investments in cleaner technologies and process innovations are necessary to meet Denmark's aggressive climate targets and EU environmental requirements. Pharmaceutical businesses also need to strike a balance between sustainability measures and preserving cost-effectiveness and production efficiency. Changes in sourcing procedures and supply networks are also necessary for this shift. The Danish pharmaceutical industry must overcome the difficult task of successfully incorporating green practices while maintaining its competitiveness in order to keep up with worldwide sustainability trends. Key Players Analysis: Company Overview, Key Persons, Recent Development & Strategies, SWOT Analysis, Sales Analysis Novo Nordisk A/S H. Lundbeck A/S Leo Pharma A/S Orifarm Group A/S ALK-Abell A/S Xellia ApS Takeda Pharma A/S Sandoz A/S Ferring Pharmaceuticals A/S FUJIFILM Diosynth Biotechnologies Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $3.81 Billion Forecasted Market Value (USD) by 2033 $5.2 Billion Compound Annual Growth Rate 3.5% Regions Covered Denmark Key Topics Covered: 1. Introduction2. Research & Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Denmark Pharmaceutical Market5.1 Historical Market Trends5.2 Market Forecast6. Market Share Analysis6.1 By Therapeutic Class6.2 By Drug Type6.3 By Prescription Type6.4 By Distribution Channel7. Therapeutic Class7.1 Cancer7.1.1 Market Analysis7.1.2 Market Size & Forecast7.2 Infectious Diseases7.3 Cardiovascular Diseases7.4 Diabetes7.5 Respiratory Diseases7.6 Central Nervous System Disorders7.7 Autoimmune Diseases7.8 Others8. Drug Type8.1 Branded8.1.1 Market Analysis8.1.2 Market Size & Forecast8.2 Generic9. Prescription Type9.1 OTC Drugs9.1.1 Market Analysis9.1.2 Market Size & Forecast9.2 Prescription Drugs10. Distribution Channel10.1 Hospital Pharmacy10.1.1 Market Analysis10.1.2 Market Size & Forecast10.2 Retail Pharmacy10.3 Others11. Value Chain Analysis12. Porter's Five Forces Analysis12.1 Bargaining Power of Buyers12.2 Bargaining Power of Suppliers12.3 Degree of Competition12.4 Threat of New Entrants12.5 Threat of Substitutes13. SWOT Analysis13.1 Strength13.2 Weakness13.3 Opportunity13.4 Threats14. Pricing Benchmark Analysis14.1 Novo Nordisk A/S14.2 H. Lundbeck A/S14.3 Leo Pharma A/S14.4 Orifarm Group A/S14.5 ALK-Abell A/S14.6 Xellia ApS14.7 Takeda Pharma A/S14.8 Sandoz A/S14.9 Ferring Pharmaceuticals A/S14.10 FUJIFILM Diosynth Biotechnologies15. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Danish Pharmaceutical Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

A Danish zoo is seeking unwanted pets — to feed to its predators
A Danish zoo is seeking unwanted pets — to feed to its predators

Washington Post

time3 hours ago

  • Washington Post

A Danish zoo is seeking unwanted pets — to feed to its predators

A zoo in Denmark has put out a call for people to donate unwanted pets and animals — including chickens, rabbits and guinea pigs — so they can be turned into feed for its predators. Aalborg Zoo wrote on social media last week that healthy animals it receives will be 'gently euthanized' by trained staff and then used as food for the predators, adding that this would help the zoo replicate its animals' natural food chain. 'That way, nothing goes to waste — and we ensure natural behavior, nutrition and well-being of our predators,' the zoo said, adding that some of its animals needed to eat 'whole' prey. The zoo also accepts donations of certain horses, which are also euthanized and then used as food. Online, critics balked at the idea of pets being fed to zoo animals, calling it a 'cheap publicity stunt,' 'disrespectful' and 'sick,' and a policy they say could encourage pet neglect. However, others said it was a good option for people whose pets are nearing the end of their lives and a way to make sure their deaths serve a purpose. Experts say donation can be a more cost-effective and natural way of feeding zoo animals who might otherwise be fed meat from commercial sources that can come from animals raised in poor conditions. 'If you agree to the general principle that you have carnivorous animals in a zoo, you somehow succumb to the necessity that you have to feed them animal material,' Marcus Clauss, co-director of the Clinic for Zoo Animals, Exotic Pets and Wildlife at the University of Zurich, said in an interview. 'If you do this in a way that is not primarily directed at economics, but at animal welfare, you will strive to get animals that had high welfare, ideally.' Aalborg Zoo did not immediately respond to a request for comment Tuesday. In a statement shared with the outlet Popular Science, spokeswoman Pia Nielsen said the practice of feeding carnivorous animals with smaller livestock has been used at Aalborg Zoo for many years and is common in Denmark. 'When keeping carnivores, it is necessary to provide them with meat, preferably with fur, bones, etc., to give them as natural a diet as possible. Therefore, it makes sense to allow animals that need to be euthanized for various reasons to be of use in this way,' Nielsen told Popular Science. 'In Denmark, this practice is common, and many of our guests and partners appreciate the opportunity to contribute.' Zoos in other countries also accept donations of livestock, or deceased animals, to feed their predators. The Wild Spirit Wolf Sanctuary in New Mexico, for example, states on its website that it accepts donations of 'livestock that has passed away or needs to be humanely euthanized' to feed its wolves and recommends donation over 'having to dispose of the deceased in a landfill, or go through the costly process of cremation.' The Alaska Zoo in Anchorage recently put out a call for frozen meat and fish donations for its animals. Clauss said that when horses are slaughtered, 'you have a huge amount of animal — meat, bones, etc. — that goes to waste in our system because it's not used by humans.' He said he supports zoos offering people the option of donating their horses if the alternative is that zoos purchase horsemeat to feed their carnivores. 'Why not get it that way directly?' Clauss acknowledged concerns that encouraging people to donate animals might mean fewer unwanted pets are placed in shelters. But he said pet shelters in many countries, including the United States, are overcrowded and can't always ensure optimal conditions for the pets in their care, so that option might not guarantee a higher welfare for the unwanted animals. And he said that forcing someone who doesn't want or can't afford their pet to keep them may also not be good for the animal. 'People who want to get rid of their animals will find a way of doing that,' he said. In response to the call for donations by the Aalborg Zoo, several Facebook users wrote that they took their horses to be donated there and praised the zoo's handling of their animals, while others wrote that they were planning to donate their horses in the future. It was not immediately clear how the donated animals would be euthanized. On Facebook, the zoo said trained professionals worked to make the deaths as quick and painless as possible.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store